Dolan Communications

Magnet Works Ltd is a company based in Fenton, MO that specializes in the production and distribution of magnetic products. With a focus on quality and innovation, Magnet Works Ltd serves a diverse range of industries and customers seeking magnetic solutions for various applications. Generated from their business information

CrisisGo is a leading provider of safety communication technology and devices, empowering organizations to prevent, prepare, respond, and recover from critical events with ease. Their comprehensive ecosystem covers all phases of emergency management, offering easy-to-use applications, devices, and integrations for schools and businesses. With CrisisGo, every person in a building becomes a responder, equipped with the tools to quickly identify and communicate risks. Their innovative solutions, such as the Siyata SD7 mobile push-to-talk device, enhance communication and provide a next-generation panic button for immediate emergency alerts. Trusted by school districts and organizations nationwide, CrisisGo is revolutionizing crisis response and ensuring the safety of teachers, staff, and students.Generated from the website

Galera Therapeutics is a biopharmaceutical company based in St. Louis, Missouri, specializing in the development of treatments to mitigate the harmful effects of radiation therapy. Led by Dr. J. Mel Sorensen, the company has raised $60 million through an initial public offering and is focused on advancing its lead drug candidate, GC4419, for the treatment of severe oral mucositis in patients with head and neck cancer. With a team of 26 employees, Galera operates locally at the Helix Center in the 39 North innovation district and has received support from St. Louis investors such as the St. Louis Arch Angels, BioGenerator, and Cultivation Capital. The company's IPO follows a successful Series C financing round of $150 million, making it one of the largest funding rounds for a bioscience company in St. Louis. Galera's mission is to improve the quality of life for cancer patients undergoing radiation therapy through innovative drug development.Generated from the website